The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of histopathology, stromal tumor infiltrating lymphocytes (sTILs) and adjuvant chemotherapy (AdjCT) in early stage triple negative breast cancer (TNBC).
 
Roberto Antonio Leon-Ferre
No Relationships to Disclose
 
Mei-Yin Polley
No Relationships to Disclose
 
Heshan Liu
No Relationships to Disclose
 
Judith A. Gilbert
No Relationships to Disclose
 
Victoria Cafourek
No Relationships to Disclose
 
David W. Hillman
No Relationships to Disclose
 
Ahmed Elkhanany
No Relationships to Disclose
 
Margaret Akinhanmi
No Relationships to Disclose
 
Vivian Negron
No Relationships to Disclose
 
Judy Caroline Boughey
Research Funding - Myriad Genetics (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Minetta C. Liu
Research Funding - Celgene (Inst); Eisai (Inst); GRAIL (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Veridex (Inst)
Travel, Accommodations, Expenses - Celgene; GRAIL; Merck
 
James N. Ingle
No Relationships to Disclose
 
Krishna R. Kalari
No Relationships to Disclose
 
Fergus Couch
No Relationships to Disclose
 
Daniel W. Visscher
Patents, Royalties, Other Intellectual Property - Mayo Clinic (Inst)
 
Matthew P. Goetz
Consulting or Advisory Role - Lilly (Inst)
Research Funding - Lilly; Pfizer